The mRNA expression in PBMCs from patients with MO six months after RYGB was significantly correlated with several biochemical variables, including triglycerides, HDL, ALT, albumin, NAFLD FS, insulin, and HOMA-IR (Figure 3). The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.